期刊
EUROPEAN JOURNAL OF EPIDEMIOLOGY
卷 29, 期 10, 页码 777-790出版社
SPRINGER
DOI: 10.1007/s10654-014-9952-x
关键词
BiomarCaRE; Biomarker; Cardiovascular Risk Assessment; MORGAM; EU
资金
- European Union [HEALTH-F2-2011-278913]
- Medical Research Council [MC_CF023241] Funding Source: researchfish
Biomarkers are considered as tools to enhance cardiovascular risk estimation. However, the value of biomarkers on risk estimation beyond European risk scores, their comparative impact among different European regions and their role towards personalised medicine remains uncertain. Biomarker for Cardiovascular Risk Assessment in Europe (BiomarCaRE) is an European collaborative research project with the primary objective to assess the value of established and emerging biomarkers for cardiovascular risk prediction. BiomarCaRE integrates clinical and epidemiological biomarker research and commercial enterprises throughout Europe to combine innovation in biomarker discovery for cardiovascular disease prediction with consecutive validation of biomarker effectiveness in large, well-defined primary and secondary prevention cohorts including over 300,000 participants from 13 European countries. Results from this study will contribute to improved cardiovascular risk prediction across different European populations. The present publication describes the rationale and design of the BiomarCaRE project.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据